摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-allyl-4-nitrocatechol | 189683-06-5

中文名称
——
中文别名
——
英文名称
3-allyl-4-nitrocatechol
英文别名
2-allyl-4-nitrocatechol;4-Nitro-3-(prop-2-en-1-yl)benzene-1,2-diol;4-nitro-3-prop-2-enylbenzene-1,2-diol
3-allyl-4-nitrocatechol化学式
CAS
189683-06-5
化学式
C9H9NO4
mdl
——
分子量
195.175
InChiKey
IUGBJPUICZATIE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    86.3
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    博舒替尼杂质17sodium hydroxide盐酸 作用下, 以 二甲基亚砜 为溶剂, 反应 3.5h, 生成 2-allyloxy-4-nitrophenol3-allyl-4-nitrocatechol
    参考文献:
    名称:
    [EN] ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXANS
    [FR] DERIVES AZAHETEROCYCLYLMETHYLIQUES DE BENZODIOXANES A FUSION HETEROCYCLIQUE A EFFET ANTIDEPRESSEUR
    摘要:
    该公式化合物用于治疗抑郁症(包括但不限于重度抑郁障碍、儿童抑郁和慢性抑郁)、焦虑症、恐慌障碍、创伤后应激障碍、经前期失调性障碍(也被称为经前综合症)、注意力缺陷障碍(伴有和不伴有多动症)、强迫症、社交焦虑障碍、广泛性焦虑障碍、肥胖、厌食症和暴食症、血管运动性潮红、可卡因和酒精成瘾、性功能障碍及相关疾病。
    公开号:
    WO2004024730A1
点击查看最新优质反应信息

文献信息

  • Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoxaline
    申请人:Wyeth
    公开号:US20020183329A1
    公开(公告)日:2002-12-05
    Compounds of the formula: 1 are useful for the treatment of depression and other diseases such as obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders caused by ethanol or cocaine abuse and related illnesses.
    该公式化合物用于治疗抑郁症和其他疾病,如强迫症、恐慌发作、广泛性焦虑障碍、社交焦虑障碍、性功能障碍、进食障碍、肥胖症、由乙醇或可卡因滥用引起的成瘾障碍以及相关疾病。
  • Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-Dioxino[2,3-f]quinoxaline
    申请人:Wyeth
    公开号:US20040077652A1
    公开(公告)日:2004-04-22
    Compounds of the formula: 1 are useful for the treatment of depression and other diseases such as obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders caused by ethanol or cocaine abuse and related illnesses.
    该式化合物:1对治疗抑郁症和其他疾病(如强迫症、恐慌发作、广泛性焦虑障碍、社交焦虑障碍、性功能障碍、进食障碍、肥胖症、由乙醇或可卡因滥用引起的成瘾障碍及相关疾病)具有益处。
  • Antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7H-[1,4]dioxino[2,3-e]indole
    申请人:Wyeth
    公开号:US20020183352A1
    公开(公告)日:2002-12-05
    Compounds of the formula 1 are useful in the treatment of central nervous system disorders including depression, obsessive compulsive disorder, panic attacks, generalized anxiety disorder, sexual dysfunction, eating disorders and addictive disorders caused by ethanol or cocaine abuse.
    公式1的化合物在治疗中枢神经系统疾病方面非常有用,包括抑郁症、强迫症、恐慌症、广泛性焦虑障碍、性功能障碍、进食障碍以及由乙醇或可卡因滥用引起的成瘾障碍。
  • ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 7,8-DIHYDRO-1,6,9-TRIOXA-3-AZA-CYCLOPENTA[A]NAPHTHALENE
    申请人:Wyeth
    公开号:US20030134871A1
    公开(公告)日:2003-07-17
    Compounds of the formula: 1 useful for the treatment of depression and other diseases such as obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders caused by ethanol or cocaine abuse and related illnesses.
    这种化合物的公式:1可用于治疗抑郁症和其他疾病,如强迫症、恐慌发作、广泛性焦虑障碍、社交焦虑障碍、性功能障碍、进食障碍、肥胖症、由乙醇或可卡因滥用引起的成瘾障碍及相关疾病。
  • Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diazacyclopenta[a]naphthalene
    申请人:Wyeth
    公开号:US20020183351A1
    公开(公告)日:2002-12-05
    Compounds of the formula: 1 are useful for the treatment of depression and other diseases such as obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders caused by ethanol or cocaine abuse and related illnesses.
    这种化合物的公式:1对治疗抑郁症和其他疾病非常有用,如强迫症、恐慌发作、广泛性焦虑障碍、社交焦虑障碍、性功能障碍、饮食障碍、肥胖、由乙醇或可卡因滥用引起的成瘾障碍以及相关疾病。
查看更多